Download Free Health Data News Book in PDF and EPUB Free Download. You can read online Health Data News and write the review.

This concise, practical guide helps the advocate understand the sometimes dense rules in advising patients, physicians, and hospitals, and in litigating HIPAA-related issues.
The World health statistics 2020 report is the latest annual compilation of health statistics for 194 Member States. It summarizes trends in life expectancy and causes of death and reports on progress towards the health and health related Sustainable Development Goals (SDGs) and associated targets. Four indicators of emerging public health importance relating to poliomyelitis, hypertension and obesity in adults and school age children have been included. These are part of the WHO's Thirteenth General Programme of Work 2019-2023 (GPW13), which the 71st World Health Assembly approved in May 2018. The GPW13 is largely based on the SDGs and sets out WHO's strategic direction until 2023
In the realm of health care, privacy protections are needed to preserve patients' dignity and prevent possible harms. Ten years ago, to address these concerns as well as set guidelines for ethical health research, Congress called for a set of federal standards now known as the HIPAA Privacy Rule. In its 2009 report, Beyond the HIPAA Privacy Rule: Enhancing Privacy, Improving Health Through Research, the Institute of Medicine's Committee on Health Research and the Privacy of Health Information concludes that the HIPAA Privacy Rule does not protect privacy as well as it should, and that it impedes important health research.
In the United States, some populations suffer from far greater disparities in health than others. Those disparities are caused not only by fundamental differences in health status across segments of the population, but also because of inequities in factors that impact health status, so-called determinants of health. Only part of an individual's health status depends on his or her behavior and choice; community-wide problems like poverty, unemployment, poor education, inadequate housing, poor public transportation, interpersonal violence, and decaying neighborhoods also contribute to health inequities, as well as the historic and ongoing interplay of structures, policies, and norms that shape lives. When these factors are not optimal in a community, it does not mean they are intractable: such inequities can be mitigated by social policies that can shape health in powerful ways. Communities in Action: Pathways to Health Equity seeks to delineate the causes of and the solutions to health inequities in the United States. This report focuses on what communities can do to promote health equity, what actions are needed by the many and varied stakeholders that are part of communities or support them, as well as the root causes and structural barriers that need to be overcome.
The WHO guidelines on assessing donor suitability for blood donation have been developed to assist blood transfusion services in countries that are establishing or strengthening national systems for the selection of blood donors. They are designed for use by policy makers in national blood programmes in ministries of health, national advisory bodies such as national blood commissions or councils, and blood transfusion services.
This volume of the Biostatistics and Health Sciences Set focuses on statistics applied to clinical research. The use of Stata for data management and statistical modeling is illustrated using various examples. Many aspects of data processing and statistical analysis of cross-sectional and experimental medical data are covered, including regression models commonly found in medical statistics. This practical book is primarily intended for health researchers with basic knowledge of statistical methodology. Assuming basic concepts, the authors focus on the practice of biostatistical methods essential to clinical research, epidemiology and analysis of biomedical data (including comparison of two groups, analysis of categorical data, ANOVA, linear and logistic regression, and survival analysis). The use of examples from clinical trials and epideomological studies provide the basis for a series of practical exercises, which provide instruction and familiarize the reader with essential Stata packages and commands. - Provides detailed examples of the use of Stata for common biostatistical tasks in medical research - Features a work program structured around the four previous chapters and a series of practical exercises with commented corrections - Includes an appendix to help the reader familiarize themselves with additional packages and commands - Focuses on the practice of biostatistical methods that are essential to clinical research, epidemiology, and analysis of biomedical data
The World Health Statistics series is WHO's annual compilation of health statistics for its 194 member states. World health statistics 2018 focuses on the health and health-related Sustainable Development Goals (SDGs) and associated targets by bringing together data on a wide range of health-related SDG indicators. It also links to the three SDG-aligned strategic priorities of the WHO's 13th General Programme of Work, 2019-2023. World health statistics 2018 is organised into three parts. First, in order to improve understanding and interpretation of the data presented, Part 1 outlines the different types of data used and provides an overview of their compilation, processing and analysis. The resulting statistics are then publicised by WHO through its flagship products such as the World Health Statistics series. In Part 2, summaries are provided of the current status of selected health-related SDG indicators at global and regional levels, based on data available as of early 2018. In Part 3, each of these three strategic priorities of achieving universal health coverage (UHC), addressing health emergencies and promoting healthier populations are illustrated through the use of highlight stories. In Annexes A and B, country-level statistics are presented for selected health-related SDG indicators. Annex B presents statistics at WHO regional and global levels.
Drawing on the work of the Roundtable on Evidence-Based Medicine, the 2007 IOM Annual Meeting assessed some of the rapidly occurring changes in health care related to new diagnostic and treatment tools, emerging genetic insights, the developments in information technology, and healthcare costs, and discussed the need for a stronger focus on evidence to ensure that the promise of scientific discovery and technological innovation is efficiently captured to provide the right care for the right patient at the right time. As new discoveries continue to expand the universe of medical interventions, treatments, and methods of care, the need for a more systematic approach to evidence development and application becomes increasingly critical. Without better information about the effectiveness of different treatment options, the resulting uncertainty can lead to the delivery of services that may be unnecessary, unproven, or even harmful. Improving the evidence-base for medicine holds great potential to increase the quality and efficiency of medical care. The Annual Meeting, held on October 8, 2007, brought together many of the nation's leading authorities on various aspects of the issues - both challenges and opportunities - to present their perspectives and engage in discussion with the IOM membership.